Your account is not claimed yet. You can sign up with ORCID to claim your account.

Aidar A Ishmukhametov (A A Ishmukhametov, Aydar A Ishmukhametov)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Venues

Emerging microbes & infections

Voprosy virusologii

Terapevticheskii arkhiv

Human vaccines & immunotherapeutics

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences Aug 1o 2013

Russia

General Director

Publications

Amir I Tukhvatulin, Ilya V Gordeychuk, Inna V Dolzhikova, Alina S Dzharullaeva, Marina E Krasina, Ekaterina O Bayurova, Daria M Grousova, Anna V Kovyrshina, Alla S Kondrashova, Daria V Avdoshina, Stanislav A Gulyaev, Tatiana V Gulyaeva, Andrey V Moroz, Viktoria V Illarionova, Ilya D Zorkov, Anna A Iliukhina, Artem Y Shelkov, Andrei G Botikov, Alina S Erokhova, Dmitry V Shcheblyakov, Ilias B Esmagambetov, Olga V Zubkova, Elisaveta A Tokarskaya, Daria M Savina, Yulia R Vereveyko, Anastasiya S Ungur, Boris S Naroditsky, Aidar A Ishmukhametov, Denis Yu Logunov, Alexander L Gintsburg
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates. Emerging microbes & infections 11 (1) (2022)
Liubov I Kozlovskaya, Anastasia N Piniaeva, Georgy M Ignatyev, Ilya V Gordeychuk, Viktor P Volok, Yulia V Rogova, Anna A Shishova, Anastasia A Kovpak, Yury Yu Ivin, Liliya P Antonova, Kirill M Mefyod, Lyubov S Prokosheva, Anna S Sibirkina, Yuliya Yu Tarasova, Ekaterina O Bayurova, Olga S Gancharova, Victoria V Illarionova, Grigory S Glukhov, Olga S Sokolova, Konstantin V Shaitan, Anastasia M Moysenovich, Stanislav A Gulyaev, Tatiana V Gulyaeva, Andrey V Moroz, Larissa V Gmyl, Elena G Ipatova, Mikhail P Kirpichnikov, Alexey M Egorov, Aleksandra A Siniugina, Aidar A Ishmukhametov
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerging microbes & infections 10 (1) (2021)
Dmitry Vladimirovich Bagrov, Grigory S Glukhov, Andrey V Moiseenko, Maria G Karlova, Daniil S Litvinov, Petr А Zaitsev, Liubov I Kozlovskaya, Anna A Shishova, Anastasia A Kovpak, Yury Y Ivin, Anastasia N Piniaeva, Alexey S Oksanich, Viktor P Volok, Dmitry I Osolodkin, Aidar A Ishmukhametov, Alexey M Egorov, Konstantin V Shaitan, Mikhail P Kirpichnikov, Olga S Sokolova
Structural characterization of β-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles. Microscopy research and technique (2021)
Nadezhda M Kolyasnikova, V I Zlobin, Aidar A Ishmukhametov, V V Maleyev
[History of the discovery and study of tick-borne encephalitis in Russia: three Far Eastern expeditions (1937-1939)]. Terapevticheskii arkhiv 93 (11) (2021)
T K Dzagurova, Aidar A Ishmukhametov, V A Bakhtina, V G Morozov, М V Balovneva, S S Kurashova, B Klempa, D Kruger, E A Tkachenko
[Hemorrhagic fever with renal syndrome group outbreak caused by Sochi virus.] Voprosy virusologii 64 (1) (2020)
Mikhail F Vorovitch, Karina G Grishina, Viktor P Volok, Liubov L Chernokhaeva, Konstantin V Grishin, Galina G Karganova, Aidar A Ishmukhametov
Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture. Human vaccines & immunotherapeutics 16 (9) (2020)

Aidar A Ishmukhametov.css-eqlu8i{font-size:small;padding-left:4px;} (A A Ishmukhametov, Aydar A Ishmukhametov)

Publication Activity (10 Years)

Top Topics

Top Venues

Aidar A Ishmukhametov (A A Ishmukhametov, Aydar A Ishmukhametov)